HCPCS code A4648 – Implantable tissue marker billing guide

Key takeaways

HCPCS Code A4648 covers implantable tissue markers of any type, billed per marker. Only physicians and non-facility practices bill it, typically in a physician office (POS 11).

Hospital outpatient departments bill C1879 for the same device, and Medicare packages the marker into ASC payments. Billing A4648 in a facility setting is a common cause of denial.

Documentation must include the procedure note naming the marker placed, the ICD-10 diagnosis supporting medical necessity, and the quantity of units.

A4648 is carrier-priced, so your Medicare Administrative Contractor (MAC) sets the allowance rather than a national fee schedule.

Pabau, our practice management platform, supports billing by keeping the procedure note, the patient record and the invoice in one place.

HCPCS Code A4648: Official descriptor and device description

HCPCS Code A4648 is the supply code for an implantable tissue marker. The official CMS descriptor reads: Tissue marker, implantable, any type, each. Physicians and non-facility practices bill it once for every marker placed. The phrase “any type” is deliberate, so the code covers the full range of devices placed to mark tissue for later imaging or surgical localization.

Devices that qualify under A4648 include biopsy site clips, fiducial markers and other implantable markers used in image-guided procedures.

A biopsy site clip is a small metal clip left after a core-needle biopsy, so follow-up mammography can find the sampled site. Fiducial markers are gold seeds or coils that guide radiation therapy targeting. Each one leaves a durable landmark that shows up on later imaging.

What A4648 covers and what it excludes

Some coders read “any type” as covering any implant that shows up on imaging. The code is narrower than that. It applies to devices placed to mark tissue for localization, not to every radiographically visible implant. Like other A-codes in the HCPCS supply series, it describes the device rather than the procedure that placed it.

Devices and scenarios that qualify:

• Metallic biopsy site clips placed during core-needle, vacuum-assisted, or stereotactic breast biopsy
• Fiducial markers (gold seeds, coils, or similar) placed for radiation therapy targeting in prostate, lung, or other cancer treatment
• Surgical tissue clips placed during minimally invasive procedures to mark a lesion site for later localization
• Ultrasound-visible markers placed during MRI-guided biopsy when the radiologist needs a confirmatory landmark

Devices and scenarios that do not qualify:

• Tissue markers billed in hospital outpatient departments (HOPDs), which use C1879, the C-code for the same device on the facility claim
• Markers placed in an ambulatory surgical center (ASC), where Medicare packages the marker into the ASC payment
• Clips placed during a breast biopsy reported with CPT 19081–19086, which already include clip placement and imaging guidance
• Implants serving a primary therapeutic function rather than a marking function, which have device-specific J-codes or C-codes
• Markers supplied under a manufacturer-specific code where the payer requires that code instead of the generic A4648

Clinical context: When is tissue marker HCPCS code A4648 used?

A4648 applies whenever a clinician places an implantable marker during an image-guided or surgical procedure in a physician office or other non-facility setting. The most common clinical triggers are:

• Stereotactic breast biopsy: a clip is deployed through the biopsy needle right after tissue sampling, so the radiologist can confirm the site on post-procedure mammography
• Ultrasound-guided breast biopsy: same workflow, with the marker linking the biopsy site to any future imaging
• MRI-guided biopsy: a fiducial or clip is placed so a lesion seen only on MRI can be found again on later mammograms
• Radiation oncology fiducial placement: gold seeds placed in or near a tumor (commonly prostate) before radiation planning, enabling image guidance during treatment
• Surgical site marking before neoadjuvant therapy: a marker placed at diagnosis so the tumor bed stays identifiable after chemotherapy shrinks it

The clinical rationale in every case is the same. The marker is placed so future imaging or surgery can locate the treated site precisely. That purpose, documented in the procedure note, is what ties the supply code to medical necessity.

Companion CPT codes billed with HCPCS Code A4648

A4648 is a supply code, so it always travels with a CPT code for the procedure that placed the marker. CMS lists four physician codes billed with A4648: 19499, 32553, 49411 and 55876.

Breast biopsy codes 19081–19086 are not on that list. They already include imaging guidance and clip placement, so guidance codes such as 76942 and 77021 are not reported with them either.

Diagnosis codes that support medical necessity include C50.x (malignant neoplasm of breast) and D05.x (carcinoma in situ of breast). R92.x (abnormal findings on breast imaging) and N63.x (unspecified lump in breast) also qualify. A screening encounter code does not establish the need for a marker. The operative note must link the diagnosis to the clinical reason for placing the marker.

How to differentiate A4648 from similar HCPCS codes

The most consequential distinction is between A4648 and C1879. Both describe implantable tissue markers, and the setting of service decides which one goes on a claim. The chart below follows the marker from where it was placed to the claim that carries it.

The table sets A4648 beside the two codes it is most often confused with.

A common compliance error starts with a radiology group that places markers in a hospital outpatient department under a professional services agreement. The hospital already reports the marker under C1879, so A4648 on the professional claim bills the same device twice.

Reaching for A4649 is the other slip. It is a miscellaneous code, and a tissue marker already has a specific one.

Medicare coverage and reimbursement for HCPCS Code A4648

Medicare Part B covers HCPCS Code A4648 when the marker is medically necessary and the documentation supports it. There is no National Coverage Determination (NCD) for tissue markers. Coverage is left to each MAC’s discretion (carrier judgment, coverage code C), so policy can differ between jurisdictions.

A4648 carries pricing indicator 57, which means it is carrier-priced. Your MAC sets the allowance, and the code has no national amount on the Medicare Physician Fee Schedule. Ask your MAC for the carrier-priced allowance before building charge amounts. CMS reviews HCPCS Level II codes every year, so confirm the code is still active each year.

Medicare does not generally require prior authorization for A4648. Because coverage rests on contractor judgment, a claim that paid can still be recouped on post-payment review if the note doesn’t support medical necessity. Check your MAC’s published guidance before billing a high volume of A4648 claims.

Documentation requirements for A4648 claims

Weak documentation is the underlying cause of most A4648 denials that survive the setting-of-service check. A complete, billable record for HCPCS Code A4648 includes all of the following:

• Procedure or operative note: must name the specific marker and state that it was implanted, not merely available. It must also describe the anatomical site and the clinical indication
• ICD-10-CM diagnosis code: must link directly to the clinical reason for marker placement. Generic codes like Z00.00 (routine exam) do not establish medical necessity for a supply code of this type
• Quantity of units: if more than one marker is placed, the number must appear in the note. Billing multiple units without documented multiple placements is a clear audit trigger
• Imaging report (where applicable): post-procedure mammography or fluoroscopy confirming marker position strengthens the record and satisfies some MAC documentation requirements
• Device identification: some payers require the marker brand, lot number, or catalog number, so check the MAC guidance or commercial payer policy before billing

A documentation checklist built into the procedure workflow catches these problems before the chart reaches a coder. That is where medical billing compliance starts, at the point of care rather than the billing desk.

Structured procedure templates prompt the clinician for marker type, anatomical site and unit count. Those three fields prevent most avoidable A4648 rejections, and they sit at the core of submitting a clean claim.

Common billing errors and claim denial reasons for HCPCS Code A4648

Most A4648 denials trace to one of a small number of recurring errors. Good denial management strategies for supply codes start with knowing which error type generated the denial.

• Wrong setting of service: billing A4648 with a hospital outpatient or ASC place-of-service code. HOPDs report C1879, and the ASC payment already includes the marker. This is one of the most frequent denial reasons.
• Billing A4648 with a breast biopsy code: CPT 19081–19086 already include imaging guidance and clip placement. Don’t add A4648, 76942 or 77021 to these codes.
• Missing or insufficient medical necessity documentation: the procedure note leaves out the marker or the clinical indication. Or the diagnosis code on the claim does not support the need for tissue marking.
• Incorrect unit count: billing one unit when two markers were placed, or billing multiple units when only one placement is documented. Both directions create problems.
• Payer non-coverage: some commercial payers treat tissue markers as a supply included in the global fee. They will not reimburse A4648 separately, whatever the documentation shows.
• Using A4648 instead of a device-specific code: some payers want a manufacturer-specific code, or C1879, even outside the hospital outpatient setting. Check the payer’s preferred code for the device brand.

Payer-specific policies for HCPCS Code A4648 beyond Medicare

Medicare policy sets the baseline for A4648, but commercial payers and Medicaid programs diverge in ways that change reimbursement. Knowing these revenue cycle management differences stops you from billing A4648 to plans that will deny it outright.

Commercial payers

UnitedHealthcare, Aetna, Cigna, and Blue Cross Blue Shield plans each maintain their own medical policies for tissue marker supplies. Several large commercial payers include the marker in the global fee for image-guided biopsy CPT codes, mirroring Medicare’s packaging logic. Pull the payer’s medical policy from its portal before billing A4648 to any commercial plan for the first time.

Where prior authorization is required, it is almost always tied to the procedure CPT code rather than the supply code. The marker supply follows the authorization for the procedure. If the authorization is missing or excludes the supply, A4648 will deny even if the procedure itself pays.

Medicaid

Medicaid coverage for A4648 varies by state program and cannot be generalized. Some state Medicaid programs follow Medicare guidance, while others limit coverage to specific diagnoses or exclude tissue markers as a separately billable supply. Check the state Medicaid fee schedule and policy bulletin for the jurisdiction before billing.

Tools like the PGM Billing HCPCS lookup confirm whether the code is active in the relevant program.

How Pabau supports supply code billing and documentation

Practices billing A4648 juggle three moving parts on every claim. The supply code has to match the procedure code, and the note has to name the marker. The place of service also has to fit the setting. When charges are keyed by hand, one of those slips.

Pabau keeps the patient record, the treatment note and the invoice in one system. You add the insurer to the patient record, and each invoice routes to the right payer. In the US, Pabau connects to Claim.MD, so your team can submit, track and record payments from one claims management dashboard.

Before a claim goes out, Pabau checks that details such as membership numbers and authorization codes are in place. The Send button stays disabled until they are. Your team still enters the A4648 unit count and place of service on the invoice, so check both before you send.

Send supply code claims from one dashboard

Pabau keeps patient records, treatment notes and invoices in one system, and checks claim details before your team sends them.

Book a demo

Conclusion

Treat A4648 as a setting question first. If the marker went in at a physician office, bill it per unit alongside the placement code. If it went in at a hospital outpatient department or an ASC, leave it off the professional claim.

The trade-off is a little effort up front. A structured procedure note takes the clinician a minute per case, and it saves the back-and-forth when a payer asks for proof. Practices that place fiducials or clips every week should build that note into the workflow now.

Book a demo to see how Pabau keeps your patient records, invoices and claims in one system.

Continue your research

Want to reduce claim denials across your billing team? Denial management strategies for healthcare practices covers the systematic approaches that reduce rework.

Need a cleaner submission process from charge capture to payer? What makes a clean claim explains the documentation and coding standards that prevent rejections at the first touch.

Looking to strengthen your overall billing compliance posture? Medical billing compliance essentials outlines the regulatory framework and audit risk areas that radiology and oncology practices face.

Frequently asked questions